Somatotropin treatment does not affect nonesterified fatty acid response to adrenergic injections in underfed or overfed nonlactating cows.

This experiment was conducted to determine the respective effects of bovine somatotropin (bST) and energy balance on the in vivo responses of plasma nonesterified fatty acids and glucose to isoproterenol (a nonselective beta-agonist) or epinephrine injection in nonlactating nonpregnant cows. Two groups of adult Holstein cows were either underfed (n = 4) at 75%, or overfed (n = 5) at 150% of maintenance energy requirement, respectively. Cows received or did not receive a subcutaneous injection of Sometribove (500 mg) during two experimental periods (cross-over design). Adrenergic or placebo injections (4 nmol/kg body weight of epinephrine or isoproterenol or 4 mL of sterile saline) were administered intravenously on d 7-9 after bovine somatotropin injection, 1 h before 3.5 h after feeding for under- or overfed cows, respectively. Glucose and nonesterified fatty acid responses to each challenge were calculated as area under the response curve and above the base line, from the time of challenge until 60 min postchallenge. Basal plasma nonesterified fatty acids and their response to adrenergic injections were enhanced by underfeeding. Responses of nonesterified fatty acids to isoproterenol injection were higher than they were to epinephrine injection. Basal plasma glucose was enhanced by bovine somatotropin treatment, which increased the glucose response at 5 min after adrenergic injections. Response of plasma glucose was higher after epinephrine than after isoproterenol injection. Treatment with bovine somatotropin did not change plasma nonesterified fatty acid responses to epinephrine or isoproterenol injection in under- or overfed cows, at constant energy intake, whereas underfeeding modified these responses markedly.

Retrospective study of children born to HIV-1-infected mothers in a pediatric hospital in Argentina.

The aim of this retrospective study, which included 103 children born to human immunodeficiency virus type 1 (HIV-1)- infected mothers, is to initiate a database on HIV-infected children, which has to date been unavailable in Argentina. All HIV-1 seropositive children admitted to the Pedro de Elizalde Children's Hospital in Buenos Aires from March 1, 1987, to December 31, 1992, were enrolled in this study. The number of patients enrolled dramatically increased each year during the period of study. Of the 60 infected children, 22 (36.66%) have died with a clinical diagnosis of HIV-1 infection; in 10 of those children HIV infection was also confirmed by P24 antigenemia and/or polymerase chain reaction (PCR): 20 qualified for the Centers for Disease Control and Prevention (CDC) P2D class (P2D1 = 7, P2D2 = 10, P2D3 = 3), 1 for P2C, and 1 for P2A, whose cause of death was pneumonia. The mean age of death was 14.8 months, 18 (82%) died before 18 months. When immunoglobulin G (IgG), IgM, and IgA levels were determined according to age and clinical status, significant differences (P < 0.005) were observed when both asymptomatic and symptomatic infected children (P1, P2) were compared with noninfected children (P3). A significant difference was also obtained between those children who qualified for P2 classification prior to 12 months of age who died early (at or prior to 25 months) and those who reached stage P2 after 12 months of age and have survived to date (X2 = 24.73, p < 0.0001; RR = 5.83, 2.52 < RR < 13.49).